{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T16:04:57Z","timestamp":1772208297195,"version":"3.50.1"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2017R1D1A1B03027968"],"award-info":[{"award-number":["2017R1D1A1B03027968"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Science and NCT","award":["2020R1A2C1006416"],"award-info":[{"award-number":["2020R1A2C1006416"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0232917","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T14:07:40Z","timestamp":1597759660000},"page":"e0232917","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cyclic pentapeptide cRGDfK enhances the inhibitory effect of sunitinib on TGF-\u03b21-induced epithelial-to-mesenchymal transition in human non-small cell lung cancer cells"],"prefix":"10.1371","volume":"15","author":[{"given":"Kyeong-Yong","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7509-5313","authenticated-orcid":true,"given":"Jiyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,8,18]]},"reference":[{"key":"pone.0232917.ref001","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"R Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"pone.0232917.ref002","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"JP Thiery","year":"2009","journal-title":"Cell"},{"key":"pone.0232917.ref003","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","article-title":"Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"R Siegel","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"pone.0232917.ref004","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1083\/jcb.108.6.2435","article-title":"Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion","volume":"108","author":"J Behrens","year":"1989","journal-title":"J Cell Biol"},{"key":"pone.0232917.ref005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1196\/annals.1386.024","article-title":"TGF-\u03b2 signaling in breast cancer","volume":"1989","author":"MB Buck","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"pone.0232917.ref006","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/bcr2224","article-title":"TGF-\u03b2 in breast cancer: too much, too late","volume":"11","author":"MH Barcellos-Hoff","year":"2009","journal-title":"Breast Cancer Res"},{"key":"pone.0232917.ref007","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10555-012-9375-7","article-title":"TGF-\u03b2 signalling and its role in cancer progression and metastasis","volume":"31","author":"Y Drabsch","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"pone.0232917.ref008","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/37284","article-title":"TGF-beta signaling from cell membrane to nucleus through SMAD proteins","volume":"390","author":"CH Heldin","year":"1997","journal-title":"Nature"},{"key":"pone.0232917.ref009","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1101\/gad.1350705","article-title":"Smad transcription factors","volume":"19","author":"J Massague","year":"2005","journal-title":"Genes Dev"},{"key":"pone.0232917.ref010","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","article-title":"TGF-beta signal transduction","volume":"67","author":"J Massague","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"pone.0232917.ref011","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1387\/ijdb.041794hp","article-title":"Transcriptional regulation of cadherins during development and carcinogenesis","volume":"48","author":"H Peinado","year":"2004","journal-title":"Int J Dev Biol"},{"key":"pone.0232917.ref012","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","article-title":"Twist a master regulator of morphogenesis, plays an essential role in tumor metastasis","volume":"117","author":"J Yang","year":"2004","journal-title":"Cell"},{"key":"pone.0232917.ref013","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2217\/14796694.2.6.743","article-title":"Role of TGF-\u03b2 in cancer progression","volume":"2","author":"AJ Galliher","year":"2006","journal-title":"Future Oncol"},{"key":"pone.0232917.ref014","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1091\/mbc.e08-05-0506","article-title":"Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3","volume":"19","author":"D Medici","year":"2008","journal-title":"Mol Biol Cell"},{"key":"pone.0232917.ref015","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1007\/s11033-011-1128-0","article-title":"Transforming growth factor-\u03b21 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K\/Akt and MEK\/Erk1\/2 signaling pathways","volume":"39","author":"XF Chen","year":"2012","journal-title":"Mol Biol Rep"},{"key":"pone.0232917.ref016","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1038\/emboj.2009.285","article-title":"The kinase TNIK is an essential activator of Wnt target genes","volume":"28","author":"T Mahmoudi","year":"2009","journal-title":"EMBO J"},{"key":"pone.0232917.ref017","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1158\/0008-5472.CAN-10-0306","article-title":"Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth","volume":"70","author":"M Shitashige","year":"2010","journal-title":"Cancer Res"},{"key":"pone.0232917.ref018","doi-asserted-by":"crossref","first-page":"e110180","DOI":"10.1371\/journal.pone.0110180","article-title":"A novel aminothiazole KY-05009 with potential to inhibit Traf2- and Nck-interacting kinase (TNIK) attenuates TGF-\u03b21-mediated epithelial-to-mesenchymal transition in human lung adenocarcinoma A549 cells","volume":"9","author":"J Kim","year":"2014","journal-title":"PLoS One"},{"key":"pone.0232917.ref019","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00726-016-2214-3","article-title":"Traf2- and Nck-interacting kinase (TNIK) is involved in the anti-cancer mechanism of dovitinib in human multiple myeloma IM-9 cells","volume":"48","author":"Chon Lee","year":"2016","journal-title":"Amino Acids"},{"key":"pone.0232917.ref020","doi-asserted-by":"crossref","first-page":"41091","DOI":"10.18632\/oncotarget.17056","article-title":"Synergistic inhibition effect of TNIK inhibitor KY-05009 and receptor tyrosine kinase inhibitor dovitinib on IL-6-induced proliferation and Wnt signaling pathway in human multiple myeloma cells","volume":"8","author":"Y Lee","year":"2017","journal-title":"Oncotarget"},{"key":"pone.0232917.ref021","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"MI Davis","year":"2011","journal-title":"Nat Biotechnol"},{"key":"pone.0232917.ref022","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/11318860-000000000-00000","article-title":"Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies","volume":"23","author":"GS Papaetis","year":"2009","journal-title":"BioDrugs"},{"key":"pone.0232917.ref023","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1097\/JTO.0b013e318219a973","article-title":"Phase II Study of Sunitinib in Patients With Non-Small Cell Lung Cancer and Irradiated Brain Metastases","volume":"6","author":"S Novello","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"suppl","key":"pone.0232917.ref024","doi-asserted-by":"crossref","first-page":"8040","DOI":"10.1200\/jco.2014.32.15_suppl.8040","article-title":"Sunitinib (S) switch maintenance in advanced non-small cell lung cancer (NSCLC): An ALLIANCE (CALGB 30607), randomized, placebo-controlled phase III trial","volume":"32","author":"MA Socinski","year":"2014","journal-title":"J Clin Oncol"},{"key":"pone.0232917.ref025","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1200\/JCO.2011.39.2993","article-title":"Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer: a phase III trial","volume":"30","author":"GV Scagliotti","year":"2012","journal-title":"J Clin Oncol"},{"key":"pone.0232917.ref026","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/annonc\/mdv219","article-title":"Cilengitide Combined With Cetuximab and Platinum-Based Chemotherapy as First-Line Treatment in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients: Results of an Open-Label, Randomized, Controlled Phase II Study (CERTO),","volume":"26","author":"J Vansteenkiste","year":"2015","journal-title":"Ann Oncol"},{"key":"pone.0232917.ref027","doi-asserted-by":"crossref","first-page":"189","DOI":"10.7150\/thno\/v01p0189","article-title":"Integrin targeted delivery of chemotherapeutics","volume":"1","author":"K Chen","year":"2011","journal-title":"Theranostics"},{"key":"pone.0232917.ref028","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/309030a0","article-title":"Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule","volume":"309","author":"MD Pierschbacher","year":"1984","journal-title":"Nature"},{"key":"pone.0232917.ref029","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0945-053X(03)00083-0","article-title":"The RGD story: a personal account","volume":"22","author":"E Ruoslahti","year":"2003","journal-title":"Matrix Biol"},{"key":"pone.0232917.ref030","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1146\/annurev.cellbio.12.1.697","article-title":"RGD and other recognition sequences for integrins","volume":"12","author":"E Ruoslahti","year":"1996","journal-title":"Annu Rev Cell Dev Biol"},{"key":"pone.0232917.ref031","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.2821619","article-title":"New perspectives in cell adhesion: RGD and integrins","volume":"238","author":"E Ruoslahti","year":"1987","journal-title":"Science"},{"key":"pone.0232917.ref032","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1126\/science.1069040","article-title":"Crystal structure of the extracellular segment of integrin \u03b1\u2164\u03b23 in complex with an Arg-Gly-Asp ligand","volume":"296","author":"JP Xiong","year":"2002","journal-title":"Science"},{"key":"pone.0232917.ref033","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.drup.2005.10.002","article-title":"RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature","volume":"8","author":"K Temming","year":"2005","journal-title":"Drug Resist Updat"},{"key":"pone.0232917.ref034","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.canlet.2018.12.021","article-title":"Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma","volume":"446","author":"F Bianchini","year":"2019","journal-title":"Cancer Lett"},{"key":"pone.0232917.ref035","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3390\/cancers11040531","article-title":"Efficacy of a Selective Binder of \u03b1V\u03b23 Integrin Linked to the Tyrosine Kinase Inhibitor Sunitinib in Ovarian Carcinoma Preclinical Models","volume":"11","author":"A Sartori","year":"2019","journal-title":"Cancers"},{"key":"pone.0232917.ref036","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcc.540040211","article-title":"CHARMM: A program for macromolecular energy minimization and dynamics calculations","volume":"4","author":"BR Brooks","year":"1983","journal-title":"J Comput Chem"},{"key":"pone.0232917.ref037","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"pone.0232917.ref038","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"TC Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"pone.0232917.ref039","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1158\/1078-0432.CCR-04-1087","article-title":"Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses","volume":"10","author":"L Zhao","year":"2004","journal-title":"Clin Cancer Res"},{"key":"pone.0232917.ref040","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1021\/acs.molpharmaceut.5b00935","article-title":"Cyclic RGDfK Peptide Functionalized Polymeric Nanocarriers for Targeting Gemcitabine to Ovarian Cancer Cells","volume":"13","author":"H Kulhari","year":"2016","journal-title":"Mol Pharm"},{"key":"pone.0232917.ref041","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1158\/1541-7786.MCR-09-0221","article-title":"Sustained c-Jun-NH2-kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activation","volume":"8","author":"J Wang","year":"2010","journal-title":"Mol Cancer Res"},{"key":"pone.0232917.ref042","doi-asserted-by":"crossref","first-page":"172","DOI":"10.21037\/tlcr.2016.04.07","article-title":"The role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer","volume":"5","author":"KR Jakobsen","year":"2016","journal-title":"Transl Lung Cancer Res"},{"key":"pone.0232917.ref043","doi-asserted-by":"crossref","first-page":"204","DOI":"10.7150\/ijbs.22955","article-title":"Combination Strategies Using EGFR-TKi in NSCLC Therapy: Learning from the Gap between Pre-Clinical Results and Clinical Outcomes","volume":"14","author":"Z Yang","year":"2018","journal-title":"Int J Biol Sci"},{"key":"pone.0232917.ref044","first-page":"2302","article-title":"Recent Advances in Synthesis and Identification of Cyclic Peptides for Bioapplications","volume":"17","author":"YS Ong","year":"2017","journal-title":"Curr Top Med Chem"},{"key":"pone.0232917.ref045","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.biomaterials.2011.11.012","article-title":"Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles","volume":"33","author":"Q Xu","year":"2012","journal-title":"Biomaterials"},{"key":"pone.0232917.ref046","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1021\/bc4002097","article-title":"Functionalization of small rigid platforms with cyclic RGD peptides for targeting tumors overexpressing \u03b1v\u03b23-integrins","volume":"24","author":"J Morlieras","year":"2013","journal-title":"Bioconjug Chem"},{"key":"pone.0232917.ref047","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jtho.2015.10.002","article-title":"Strategies to Improve Outcomes of Patients with EGRF-Mutant Non-Small Cell Lung Cancer: Review of the Literature","volume":"11","author":"C Zhou","year":"2016","journal-title":"J Thorac Oncol"},{"key":"pone.0232917.ref048","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"CR Chong","year":"2007","journal-title":"Nature"},{"key":"pone.0232917.ref049","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1568009615666141229152812","article-title":"Potential anti-cancer drugs commonly used for other indications","volume":"15","author":"V Hanusova","year":"2015","journal-title":"Curr Cancer Drug Targets"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T14:08:11Z","timestamp":1597759691000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232917"}},"subtitle":[],"editor":[{"given":"Pier Giorgio","family":"Petronini","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0232917","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.27.063776","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,18]]}}}